Generate a tailored SOP for Dr. Kendal Chidwick. Improve your application with a focused, well-structured draft.
Kendal Chidwick is a Postdoctoral Fellow at the National Drug and Alcohol Research Centre, UNSW Sydney. With over 20 years of experience in health research, she has spent a decade focused on maximizing the use of linked administrative datasets to inform policy decisions aimed at improving health outcomes. Currently, her research involves examining trends in Australian sales of opioids and managing opioid agonist treatment medicines, including studying the impacts of post-hospitalization opioid initiation and the introduction of long-acting injectable buprenorphine. Her past experience includes leadership roles in drug utilization and post-market surveillance at organizations like NPS MedicineWise and the Clinical Practice Research Datalink, along with involvement with Australian Government health committees and policy advisory boards. Additionally, she was a member of the National COVID-19 Clinical Evidence Taskforce's Observational Data Working Group during 2020-2021.
National Drug and Alcohol Research Centre • Sydney, Australia
Conducting research on trends in opioid sales and related treatment initiatives.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.